Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
53
NDRA Quote, Financials, Valuation and Earnings
Last price:
$7.40
Seasonality move
:
-20.79%
Day range:
$7.01 - $7.45
52-week range:
$2.90 - $168.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.64x
P/B ratio:
3.05x
Volume:
152.9K
Avg. volume:
3.3M
1-year change:
-95.21%
Market cap:
$5.3M
Revenue:
--
EPS (TTM):
-$483.49
Earnings Data
Next earnings date for NDRA
Aug 22
2025
Most recent earnings per share
-$1.86
Beat by $2.05
(May 16/2025)
Consensus Estimate
-$3.91
(May 16/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
NDRA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | -- | -- | -- | -$2.67 | -- |
| 08/22/2025 | Q2 | -- | -- | -- | -$2.27 | -- |
| 05/16/2025 | Q1 | -- | -- | -$1.86 | -$3.91 | $2.05 |
| 03/31/2025 | Q4 | -- | -- | -$7.73 | -$4.10 | -$3.63 |
| 11/15/2024 | Q3 | -- | -- | -$333.90 | -$62.30 | -$271.60 |
| 08/22/2024 | Q2 | -- | -- | -$140.00 | -$122.50 | -$17.50 |
| 05/14/2024 | Q1 | -- | -- | -$449.58 | -$472.50 | $22.92 |
| 03/28/2024 | Q4 | -- | -- | -$245.84 | -$630.00 | $384.16 |
| 11/15/2023 | Q3 | -- | -- | -$645.20 | -$752.50 | $107.30 |
| 06/30/2023 | Q2 | -- | -- | -$752.50 | -$962.50 | $210.00 |
| 03/31/2023 | Q1 | -- | -- | -$1,627.50 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$1,802.50 | -- | -- |
| 11/15/2022 | Q3 | -- | -- | -$1,907.50 | -- | -- |
| 08/12/2022 | Q2 | -- | -- | -$2,047.50 | -- | -- |
| 05/17/2022 | Q1 | -- | -- | -$2,327.50 | -- | -- |
| 03/25/2022 | Q4 | -- | -- | -$2,712.50 | -- | -- |
| 11/15/2021 | Q3 | -- | -- | -$2,100.00 | -- | -- |
| 08/12/2021 | Q2 | -- | -- | -$2,800.00 | -- | -- |
| 05/17/2021 | Q1 | -- | -- | -$2,100.00 | -- | -- |
| 03/25/2021 | Q4 | -- | -- | -$2,315.60 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$5,117.12 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$6,170.30 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$8,586.04 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$37,621.13 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$15,951.22 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$11,011.18 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$12,965.74 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$11,158.54 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$24,630.14 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$16,489.04 | -- | -- |
| 03/31/2018 | Q1 | -- | $6.2K | -$25,225.92 | -- | -- |
| 12/31/2017 | Q4 | -- | $6.9K | -$20,487.86 | -- | -- |
| 09/30/2017 | Q3 | -- | $287K | -$8,188.36 | -- | -- |
| 06/30/2017 | Q2 | -- | $57.8K | -$12,899.02 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$6,681.29 | -- | -- |
| 12/31/2016 | Q4 | -- | $515.6K | -$6,206.11 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$8,809.89 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$6,568.59 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$3,418.72 | -- | -- |
| 12/31/2015 | Q4 | -- | $255K | -$4,132.73 | -- | -- |
| 09/30/2015 | Q3 | -- | $326.1K | -$4,873.76 | -- | -- |
ENDRA Life Sciences Earnings Questions
-
How Much did ENDRA Life Sciences Generate in Revenue Last Quarter?
ENDRA Life Sciences reported -- worth of top line sales in its most recent quarter.
-
Did ENDRA Life Sciences Beat Earnings Last Quarter?
ENDRA Life Sciences announced earnings per share of -$1.86 which represents a beat of analyst forecast a -$3.91 per share.
-
Is ENDRA Life Sciences Profitable?
ENDRA Life Sciences reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for ENDRA Life Sciences EPS Next Year?
ENDRA Life Sciences's earnings are forecast to decrease from -$56.94 per share to -$47.46 per share next year representing a decrease of -74.08%.
-
When is ENDRA Life Sciences's Earnings Date?
ENDRA Life Sciences's next earnings date is August 22, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
93
EXOD alert for Jul 18
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
